72 related articles for article (PubMed ID: 38482465)
1. Masked pemphigus among pediatric patients with Castleman's disease.
Han SP; Fu LS; Chen LJ
Int J Rheum Dis; 2019 Jan; 22(1):121-131. PubMed ID: 30411519
[TBL] [Abstract][Full Text] [Related]
2. Autoreactive Antibodies Associated with Castleman Disease Triad.
Turner JA; Hakimi A; Lee H; Schowinsky JT; Sippel JM; Siegele BJ; Torres RM; Robinson WA
Case Reports Immunol; 2024; 2024():9382107. PubMed ID: 38482465
[TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
[TBL] [Abstract][Full Text] [Related]
4. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
Li P; Liu H; Li H; Li A; Yu G; Yin W
Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
[TBL] [Abstract][Full Text] [Related]
5. Hyaline Vascular Type of Unicentric Castleman Disease in a Kidney with End-Stage Renal Disease: A Case Report of a Rare Entity at an Unusual Location and a Special Clinical Setting.
Chen CH; Li HN
Diagnostics (Basel); 2022 Nov; 12(11):. PubMed ID: 36428938
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathological features of bronchiolitis obliterans requiring lung transplantation in paraneoplastic pemphigus associated with Castleman disease.
Chen W; Zhao L; Guo L; Zhao L; Niu H; Lian H; Dai H; Chen J; Wang C
Clin Respir J; 2022 Mar; 16(3):173-181. PubMed ID: 35060328
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series.
Barry KK; Plumptre I; Bazewicz CG; Green BP; Treat JR; Hughes M; Morel KD; Wiss K; Liang MG
Pediatr Dermatol; 2023 Jan; 40(1):90-95. PubMed ID: 36128651
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases.
Sun DP; Chen WM; Wang L; Wang Z; Liang JH; Zhu HY; Fan L; Wu YJ; Xu W; Li JY
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2107-2115. PubMed ID: 33544201
[TBL] [Abstract][Full Text] [Related]
9. Histone H2A-Reactive B Cells Are Functionally Anergic in Healthy Mice With Potential to Provide Humoral Protection Against HIV-1.
Agazio A; Cimons J; Shotts KM; Guo K; Santiago ML; Pelanda R; Torres RM
Front Immunol; 2020; 11():1565. PubMed ID: 32849530
[TBL] [Abstract][Full Text] [Related]
10. A CARE-compliant article: Unicentric Castleman disease presenting as a retroperitoneal mass of the upper edge of the pancreas: A case report.
Zhou YX; Ji Y; Wu S
Medicine (Baltimore); 2020 Mar; 99(11):e19515. PubMed ID: 32176100
[TBL] [Abstract][Full Text] [Related]
11. Overview of Castleman disease.
Dispenzieri A; Fajgenbaum DC
Blood; 2020 Apr; 135(16):1353-1364. PubMed ID: 32106302
[TBL] [Abstract][Full Text] [Related]
12. Clonal redemption and clonal anergy as mechanisms to balance B cell tolerance and immunity.
Burnett DL; Reed JH; Christ D; Goodnow CC
Immunol Rev; 2019 Nov; 292(1):61-75. PubMed ID: 31556969
[TBL] [Abstract][Full Text] [Related]
13. Castleman disease mimicking systemic lupus erythematosus: A case report.
Wang L; Chen H; Shi J; Tang H; Li H; Zheng W; Zhang F
Medicine (Baltimore); 2018 Sep; 97(38):e12291. PubMed ID: 30235674
[TBL] [Abstract][Full Text] [Related]
14. International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease.
van Rhee F; Voorhees P; Dispenzieri A; Fosså A; Srkalovic G; Ide M; Munshi N; Schey S; Streetly M; Pierson SK; Partridge HL; Mukherjee S; Shilling D; Stone K; Greenway A; Ruth J; Lechowicz MJ; Chandrakasan S; Jayanthan R; Jaffe ES; Leitch H; Pemmaraju N; Chadburn A; Lim MS; Elenitoba-Johnson KS; Krymskaya V; Goodman A; Hoffmann C; Zinzani PL; Ferrero S; Terriou L; Sato Y; Simpson D; Wong R; Rossi JF; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Oksenhendler E; Fajgenbaum DC
Blood; 2018 Nov; 132(20):2115-2124. PubMed ID: 30181172
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
